# Enveric Biosciences, Inc.: Form 8-K, filed May 4, 2022

- Company: [Enveric Biosciences, Inc.](/companies/envb.md) (CIK 890821)
- Form: 8-K
- Filed: 2022-05-04
- Accepted by EDGAR: May 4, 2022, 17:27 ET
- Period: 2022-05-03
- Accession: 0001493152-22-012133
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/890821/000149315222012133/form8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/890821/000149315222012133/

## Items reported

- Item 3.03: Change to security holders’ rights
- Item 5.03: Amendment to articles or bylaws
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/890821/000149315222012133/form8-k.htm

Filed May 4, 2022.
Source: SEC EDGAR, the filing index for accession 0001493152-22-012133. Last ingested by Listed: Nov 14, 2026, 20:02 ET. No prices; not investment advice.
